Aleor Dermaceuticals receives EIR from US FDA for Karakhadi formulation facility

Aleor Dermaceuticals Ltd. (Aleor), a 60:40 joint venture between Alembic Pharmaceuticals Ltd. (Alembic) and Orbicular Pharmaceutical Technologies Pvt. Ltd. (Orbicular), has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (FDA) for the inspection at Aleor’s formulation facility at Karakhadi, Gujarat.

The company said that the inspection was carried out during the period from January 6 to 8, 2020.

Alembic Pharmaceuticals is an Indian multinational pharmaceutical company headquartered in Vadodara city of Gujarat – India. It is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates.